Standard-Dose vs Flipped-Dose Nivolumab Plus Ipilimumab for Advanced Melanoma: A Systematic Review and Individual Patient Data Meta-analysis (ESMO Asia 2026) - Oct 1, 2026 - Abstract #1153eP; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Metastases • Retrospective data • Review • Melanoma • Oncology • Solid Tumor
|
|
Chen Ee Low; Hon Jen Wong; Kye Qin Yong; Audrey Mei Hui Tan; Chun En Yau; Ainsley Ryan Yan Bin Lee; Valerie S. Yang
|